What happened: UnitedHealth Group (UNH) stock gained 4% on Friday. Peers CVS (CVS), Humana (HUM), and Cigna (CI) also rose, sending the Healthcare (XLV) sector higher.
What’s moving the stock: UnitedHealth Group was raised to a Buy rating from Hold and chosen as a “Best Ideas 2027” stock at TD Cowen.
“We see UNH as an attractive story, with a credible path toward mid-high-teens EPS growth through 2028,” Ryan Langston and his team wrote on Friday.
The analyst raised its price target on the stock from $402 to $455. Langston highlighted that government Medicaid payments and commercial insurance prices are finally adjusting to cover higher medical costs.
Also, Optum Health, UnitedHealth’s care-delivery business, should see its profit margins improve as the company cuts costs and renegotiates its insurance contracts.
346.52 +16.04 (+4.85%)
As of 11:22:09 AM EST. Market Open.
What else you need to know: Earlier this week, UnitedHealth and other healthcare stocks fell as a proposed federal effort to curb healthcare fraud heightened concerns over increased expenses and possible repayment liabilities for Medicare Advantage providers.
The rule would increase audits of insurance providers and allow the Centers for Medicare & Medicaid Services (CMS) to recover improper payments.
TD Cowen acknowledged the proposal as a “potential headwind” for UnitedHealth. However, the analysts view the risk as manageable, highly likely to face legal blocks, and already priced into the stock after the sell-off.
UnitedHealth is in the midst of a turnaround plan launched last year to address declining profits, rising medical costs, and regulatory headwinds.
Ines Ferre is a senior business reporter for Yahoo Finance.